New technology has transformed human genetics. It now provides perhaps the single best opportunity to innovate and improve clinical success rates in drug development.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases
Cellular and Molecular Life Sciences Open Access 15 January 2021
-
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Acta Neuropathologica Open Access 12 March 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lewis, E.B. Nature 276, 565–570 (1978).
Fishman, M.C. & Porter, J.A. Nature 437, 491–493 (2005).
Paul, S.M. et al. Nat. Rev. Drug Discov. 9, 203–214 (2010).
Laurie, S.A. & Goss, G.D. J. Clin. Oncol. 31, 1061–1069 (2013).
Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).
Gudmundsson, J. et al. Sci. Transl. Med. 2, 62ra92 (2010).
Kannel, W.B. & Castelli, W.P. Med. Times 100, 173–175 (1972).
Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B. & Dawber, T.R. Am. J. Med. 62, 707–714 (1977).
The AIM-HIGH Investigators. N. Engl. J. Med. 365, 2255–2267 (2011).
Barter, P.J. et al. N. Engl. J. Med. 357, 2109–2122 (2007).
Schwartz, G.G. et al. N. Engl. J. Med. 367, 2089–2099 (2012).
Voight, B.F. et al. Lancet 380, 572–580 (2012).
Cohen, J. et al. Nat. Genet. 37, 161–165 (2005).
Zhao, Z. et al. Am. J. Hum. Genet. 79, 514–523 (2006).
Hooper, A.J., Marais, A.D., Tanyanyiwa, D.M. & Burnett, J.R. Atherosclerosis 193, 445–448 (2007).
Lambert, G., Sjouke, B., Choque, B., Kastelein, J.J. & Hovingh, G.K. J. Lipid Res. 53, 2515–2524 (2012).
Haddad, L. et al. J. Lipid Res. 40, 1113–1122 (1999).
Abifadel, M. et al. Nat. Genet. 34, 154–156 (2003).
Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr. & Hobbs, H.H. N. Engl. J. Med. 354, 1264–1272 (2006).
Benn, M., Nordestgaard, B.G., Grande, P., Schnohr, P. & Tybjaerg-Hansen, A. J. Am. Coll. Cardiol. 55, 2833–2842 (2010).
J. Am. Med. Assoc. 251, 351–364 (1984).
J. Am. Med. Assoc. 251, 365–374 (1984).
Stamler, J., Wentworth, D. & Neaton, J.D. J. Am. Med. Assoc. 256, 2823–2828 (1986).
Pekkanen, J. et al. N. Engl. J. Med. 322, 1700–1707 (1990).
Wong, N.D., Wilson, P.W. & Kannel, W.B. Ann. Intern. Med. 115, 687–693 (1991).
Rossouw, J.E., Lewis, B. & Rifkind, B.M. N. Engl. J. Med. 323, 1112–1119 (1990).
Wilson, P.W. et al. Circulation 97, 1837–1847 (1998).
Lloyd-Jones, D.M., Larson, M.G., Beiser, A. & Levy, D. Lancet 353, 89–92 (1999).
Grundy, S.M. et al. Circulation 110, 227–239 (2004).
Kolodgie, F.D. et al. Heart 90, 1385–1391 (2004).
LaRosa, J.C. et al. N. Engl. J. Med. 352, 1425–1435 (2005).
Cannon, C.P., Steinberg, B.A., Murphy, S.A., Mega, J.L. & Braunwald, E. J. Am. Coll. Cardiol. 48, 438–445 (2006).
Cholesterol Treatment Trialists', (CTT) Collaboration et al. Lancet 376, 1670–1681 (2010).
Rashid, S. et al. Proc. Natl. Acad. Sci. USA 102, 5374–5379 (2005).
Qian, Y.W. et al. J. Lipid Res. 48, 1488–1498 (2007).
Goldstein, J.L. & Brown, M.S. Arterioscler. Thromb. Vasc. Biol. 29, 431–438 (2009).
Horton, J.D., Cohen, J.C. & Hobbs, H.H. J. Lipid Res. 50 (suppl.), S172–S177 (2009).
Steinberg, D. & Witztum, J.L. Proc. Natl. Acad. Sci. USA 106, 9546–9547 (2009).
Dhankhar, A., Evers, M. & Moller, M. in McKinsey Perspectives on Drug and Device R&D, 2–11 (2012).
Holm, H. et al. Nat. Genet. 43, 316–320 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Authors employed by Amgen and deCODE.
Rights and permissions
About this article
Cite this article
Kamb, A., Harper, S. & Stefansson, K. Human genetics as a foundation for innovative drug development. Nat Biotechnol 31, 975–978 (2013). https://doi.org/10.1038/nbt.2732
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2732
This article is cited by
-
Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases
Cellular and Molecular Life Sciences (2021)
-
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Acta Neuropathologica (2020)
-
Drug development in the era of precision medicine
Nature Reviews Drug Discovery (2018)
-
Genetics of Schizophrenia: Ready to Translate?
Current Psychiatry Reports (2017)
-
Integrating Genomics into Drug Discovery and Development: Challenges and Aspirations
Pharmaceutical Medicine (2017)